CD47 and lung carcinoma: Additional studies are needed to determine (i) whether phagocytosis induced by CD47 blockade in lung cancer is differentially executed by M1 versus M2 macrophages as previously suggested [34], and (ii) whether immune-independent effects of CD47 inhibition also contribute to its anti-tumor efficacy.